This is the authors' abstract. We don't add key points for this paper.
C oronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China in 2019 and spread around the world in 2020.By August 2021, >200 million persons were infected by SARS-CoV-2 and >4 million had died (1).A large proportion of infected persons remain asymptomatic or have only mild symptoms (2,3).The role of all infected persons should be considered in the maintenance of disease transmission, especially because asymptomatic or mildly symptomatic persons often are not tested or reported to public health authorities (4).In addition, because of economic, political, and social difficulties, molecular tests for detecting SARS-CoV-2 often are limited, particularly in developing countries (5,6).In this context, alternative measures must be explored to generate reliable data that enable government decisions to contain viral spread.Several studies report a rapid immune response that culminates in the production of SARS-CoV-2 antibodies in the first weeks after infection (5-8).Assessment of serologic SARS-CoV-2 IgG can be an essential tool to measure the dynamics of virus transmission.Some authors hypothesized that serosurveillance in blood donors can help monitor the evolution of SARS-CoV-2 infections (9-11).We conducted a large longitudinal study using the records of reported CO-VID-19 cases and SARS-CoV-2 serology results from blood donors as inputs into a modified susceptibleexposed-infected-recovered (SEIR) epidemic model ( 12).The proposed model delivers daily estimates of relevant variables that usually stay hidden, including the transmission rate and the cumulative number of reported and unreported cases of infection.We considered the continuous change of the transmission rate, making the estimated variables compatible with the shifting conditions of disease transmission.We used the monthly estimates of cumulative incidence provided by serologic analysis of blood samples to estimate the proportion of reported and unreported cases.The purpose of the model is to constitute a platform for integrating and interpretating information coming from different sources.Our study also provides evidence supporting the possibility of using serology from blood samples collected in blood donation centers to estimate the accumulated incidence of disease.Our results cover blood samples collected in 7 blood donation centers.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chaves et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: